Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26F9AT8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,727
Award facts
- Contract value 100% obligated
- $12,727.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,727.26 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed-price contract, which is not set-aside, will be performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The award reflects the company's capability to meet federal procurement requirements through competitive award processes, providing essential pharmaceutical support to the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9AT8?
SPE2DR26F9AT8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F9AT8 worth?
The government has obligated $12,727 on SPE2DR26F9AT8.
Is contract SPE2DR26F9AT8 an order under another contract?
Yes. SPE2DR26F9AT8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AT8 competed?
The extent of competition for SPE2DR26F9AT8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award